Edition:
India

Achieve Life Sciences Inc (ACHV.OQ)

ACHV.OQ on NASDAQ Stock Exchange Capital Market

1.38USD
23 Feb 2018
Change (% chg)

$-0.03 (-2.13%)
Prev Close
$1.41
Open
$1.46
Day's High
$1.46
Day's Low
$1.35
Volume
24,563
Avg. Vol
69,951
52-wk High
$7.04
52-wk Low
$1.15

Chart for

About

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisine for smoking cessation. The Company’s focus is to address the global smoking health epidemic, which is the leading cause of preventable death and is responsible for nearly six million deaths annually... (more)
No analyst recommendations are available for .

Overall

Beta: 1.95
Market Cap(Mil.): $22.44
Shares Outstanding(Mil.): 10.95
Dividend: --
Yield (%): --

Financials

BRIEF-Achieve qtrly loss per share $0.90‍​

* Achieve Life Sciences Inc qtrly loss per share $0.90‍​ Source text for Eikon: Further company coverage:

10 Nov 2017

BRIEF-Achieve Life Sciences entered into exclusive supply agreement with Sopharma AD

* Achieve Life Sciences -‍ co entered into exclusive supply agreement with Sopharma AD for manufacture of Cytisine API and finished tablets​

26 Oct 2017

BRIEF-ACHIEVE LIFE SCIENCES COMMENCES ADVANCEMENT OF CYTISINE CLINICAL DEVELOPMENT PROGRAM

* ACHIEVE LIFE SCIENCES INC - ANNOUNCES COMMENCEMENT OF A MULTI-DOSE STUDY TO EVALUATE BOTH PK AND PD CHARACTERISTICS OF CYTISINE

04 Oct 2017

BRIEF-Achieve announces share purchase agreement with Lincoln Park Capital Fund

* Achieve announces share purchase agreement with Lincoln Park Capital Fund LLC

15 Sep 2017

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $132.02 +2.11
Novartis AG (NOVN.S) CHF79.38 -0.60
Pfizer Inc. (PFE.N) $36.26 +0.52
Roche Holding Ltd. (ROG.S) CHF222.05 -1.25
Roche Holding Ltd. (RO.S) CHF225.80 -0.60
Merck & Co., Inc. (MRK.N) $54.87 +0.30
Bayer AG (BAYGn.DE) €97.92 -0.52
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €65.05 +0.16
Eli Lilly and Co (LLY.N) $78.75 +1.56

Earnings vs. Estimates